H2020-JTI-IMI2-2016-09-two-stage · DEVELOPMENT OF IMMUNE TOLERANCE THERAPIES FOR THE TREATMENT OF RHEUMATIC DISEASES · Opportunity · GRANTIBASE · GRANTIBASE